Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Absorbed dose determination for interstitial 125I boost therapy.

F M Waterman, K A Strubler

    Medical Physics
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy.

    International journal of cancer·2002
    Same author

    Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry.

    International journal of radiation oncology, biology, physics·2001
    Same author

    Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.

    Seminars in urologic oncology·2000
    Same author

    The impact of postimplant edema on the urethral dose in prostate brachytherapy.

    International journal of radiation oncology, biology, physics·2000
    Same author

    Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.

    Techniques in urology·2000
    Same author

    Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?

    Techniques in urology·2000
    Same journal

    Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

    Medical physics·2026
    Same journal

    Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

    Medical physics·2026
    Same journal

    Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

    Medical physics·2026
    Same journal

    Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

    Medical physics·2026
    Same journal

    Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

    Medical physics·2026
    Same journal

    Development and evaluation of an in vivo dose-based monitoring system for electron FLASH radiation therapy.

    Medical physics·2026
    See all related articles

    Iodine-125 brachytherapy can enhance cancer treatment for unresectable pancreatic and lung tumors. Calculations show seed spacing and activity have minimal impact on dose delivery for various tumor shapes.

    Area of Science:

    • Oncology
    • Medical Physics
    • Radiotherapy

    Background:

    • Iodine-125 (125I) brachytherapy is employed to augment external beam radiation for unresectable pancreatic and lung cancers.
    • Accurate dosimetry is crucial for optimizing treatment efficacy and minimizing toxicity.

    Purpose of the Study:

    • To calculate the required 125I activity for achieving a target peripheral dose in tumors.
    • To analyze the influence of tumor geometry and seed distribution on dose calculations.

    Main Methods:

    • Dose calculations were performed for spherical, ellipsoidal, and cylindrical tumor models.
    • Investigated the impact of both uniform and random seed arrangements within the implants.
    • Assessed the relationship between 125I activity and average tumor dimensions.

    Related Experiment Videos

    Main Results:

    • The average peripheral dose showed minimal sensitivity to seed distribution (uniform vs. random) and seed activity.
    • Calculations provide a method to determine 125I activity based on average tumor dimensions.
    • The average tumor dose was consistently found to be approximately 20% higher than the average peripheral dose.

    Conclusions:

    • 125I implant dosimetry for pancreatic and lung tumors is relatively robust regarding seed spacing and activity.
    • The presented calculations can guide treatment planning for 125I boost therapy.
    • Understanding the dose distribution relative to tumor dimensions is key for effective brachytherapy.